Pharmacology Of Drug-Tranexamic Acid

Mechanism of Action Tranexamic acid exerts antifibrinolytic effect by forming a reversible complex with plasminogen through the lysine binding site of fibrin and thus displaces the plasminogen from the fibrin surface ; preventing the binding of plasmin to fibrinogen or fibrin monomers. It inhibits the activation of plasminogen (i.e. formation of plasmin). It also acts as a weak non competitive inhibitor of plasmin and blocks it`s action on fibrin. Pharmaco Kinetics Absorption: About 40% is absorbed orally. Distribution: Widely distributed in the body. Excretion: Excreted mainly as unchanged drug. Half Life 2 hours Adverse Effects 1.Nausea 2.Diarrhoea 3.Gastrointestinal problems 4.Headache 5.Hypotension 6.Giddiness 7.Thrombophlebitis at injected vein 8.Impairment of Colour vision ContraIndications 1.Thromboembolic disorders 2.Subarachnoid haemorrhage 3.Massive upper urinary tract haemorrhage 4.Colour vision disorders 5.Thrombophlebitis 6.Hepatic impairment 7.Severe renal impairment Special Precautions 1.Avoid rapid I.V. administration 2.Lower dosage adjustment is required in renal impairment 3.Monitor liver functioning during long term use Pregnancy Contraindicated Breast Feeding Use with caution Old Age Use with caution Indications 1.Surgical procedures 2.Menorrhagia 3. Metrorrhagia 4.Post partum haemorrhage 5.Haemorrhage after abortion 6.Haemorrhage due to contraceptive device insertion 7.Tooth extractions and haemorrhage in other dental procedures 8.Epistaxis 9.Haemoptysis 10.Gastrointestinal bleeding 11.Prostatectomy 12.Tonsillectomy 13.Fibrinolysis 14.Ocular trauma 15.Orthopedic surgery 16.Cardiovascular surgery Dosage Oral: 3 to 4gm/day in 3 to 4 divided doses or 15 to 25mg/kg body wt. 3 to 4 times daily. I.V.: 1.5 to 3gm/day in 3 divided doses or 10 to 15mg/kg body wt. 3 times daily. Administered as slow